Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
63.31
+2.77 (4.58%)
At close: Jul 7, 2026, 4:00 PM EDT
63.37
+0.06 (0.09%)
After-hours: Jul 7, 2026, 4:10 PM EDT
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $6.12 billion as of July 7, 2026. Its market cap has increased by 148.85% in one year.
Market Cap
6.12B
Enterprise Value
4.79B
1-Year Change
148.85%
Ranking
Category
Stock Price
$63.31
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $6.12B, an increase of 4,203.72%. That is a compound annual growth rate of 38.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 6.12B | 76.70% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 6.58B |
| Ligand Pharmaceuticals | 6.33B |
| CG Oncology | 6.21B |
| Definium Therapeutics | 5.87B |
| CRISPR Therapeutics AG | 5.79B |
| Legend Biotech | 5.79B |
| Belite Bio | 5.77B |
| Erasca | 5.74B |